MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, CODX made $145,954 in revenue. -$9,140,038 in net income. Net profit margin of -6262.27%.

Income Overview

Revenue
$145,954
Net Income
-$9,140,038
Net Profit Margin
-6262.27%
EPS
-$4.06
Unit: Dollar
Revenue Breakdown
    • Total revenue-US
    • Total revenue-Non Us

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
total revenue
145,954 263,922 145,380 162,910
Cost of revenue
193,768 142,396 26,285 32,106
Gross profit (loss)
-47,814 121,526 119,095 130,804
Sales and marketing
467,955 545,451 568,937 609,713
General and administrative
2,503,126 1,869,207 1,815,945 2,599,982
Research and development
5,934,071 5,099,086 4,480,678 4,687,459
Depreciation and amortization
255,445 267,566 267,383 291,414
Impairment charges
-18,882,000 --
Total operating expenses
9,160,597 26,663,310 7,132,943 8,188,568
Loss from operations
-9,208,411 -26,541,784 -7,013,848 -8,057,764
Realized gain on investments
-0 41,542 340,358
Gain (loss) on disposition of assets
--74,915* 4,000 -9,004
Interest income, net
6,974 253,979 13,194 12,158
Gain on remeasurement of acquisition contingencies
75,280 118,417* -42,345 10,222
Gain on equity method investment in joint ventures
-13,361 24,862 -55,959 -13,760
Total other income, net
68,893 322,343 -39,568 339,974
Loss before income taxes
-9,139,518 -26,219,441 -7,053,416 -7,717,790
Income tax provision
520 -473,716 -1,166,593 12,327
Net loss
-9,140,038 -25,745,725 -5,886,823 -7,730,117
Change in net unrealized gains (losses) on marketable securities, net of tax
--94,888 -39,180 -196,585
Total other comprehensive income (loss)
--94,888 -39,180 -196,585
Comprehensive loss
-9,140,038 -25,840,613 -5,926,003 -7,926,702
Basic EPS
-4.06 0.264 -0.16 -0.23
Diluted EPS
-4.06 0.264 -0.16 -0.23
Basic Average Shares
2,253,474 -97,727,475 37,890,923 33,108,399
Diluted Average Shares
2,253,474 -97,727,475 37,890,923 33,108,399
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive loss-$9,140,038 (-19.93%↓ Y/Y)Net loss-$9,140,038 (-21.33%↓ Y/Y)Gain onremeasurement of acquisition...$75,280 (-89.50%↓ Y/Y)Interest income, net$6,974 (-48.72%↓ Y/Y)Loss before incometaxes-$9,139,518 (-21.52%↓ Y/Y)Income tax provision$520 (-95.67%↓ Y/Y)Total other income,net$68,893 (-93.32%↓ Y/Y)Gain on equity methodinvestment in joint...-$13,361 (-825.28%↓ Y/Y)Revenue From ContractWith Customer...$81,054 Revenue From ContractWith Customer...$64,900 Loss from operations-$9,208,411 (-7.68%↓ Y/Y)Total revenue-US$81,054 Total revenue-Non Us$64,900 Total operatingexpenses$9,160,597 (6.76%↑ Y/Y)Gross profit (loss)-$47,814 (-266.67%↓ Y/Y)total revenue$145,954 (190.30%↑ Y/Y)Research and development$5,934,071 (21.85%↑ Y/Y)General andadministrative$2,503,126 (-9.74%↓ Y/Y)Sales and marketing$467,955 (-28.78%↓ Y/Y)Depreciation andamortization$255,445 (-8.91%↓ Y/Y)Cost of revenue$193,768 (797.49%↑ Y/Y)

Co-Diagnostics, Inc. (CODX)

Co-Diagnostics, Inc. (CODX)